GB9901338D0 - Therapeutic combinations - Google Patents

Therapeutic combinations

Info

Publication number
GB9901338D0
GB9901338D0 GB9901338A GB9901338A GB9901338D0 GB 9901338 D0 GB9901338 D0 GB 9901338D0 GB 9901338 A GB9901338 A GB 9901338A GB 9901338 A GB9901338 A GB 9901338A GB 9901338 D0 GB9901338 D0 GB 9901338D0
Authority
GB
Grant status
Grant
Patent type
Prior art keywords
therapeutic combinations
therapeutic
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB9901338A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme Corp
Original Assignee
Merck Sharp & Dohme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

GB9901338A 1999-01-21 1999-01-21 Therapeutic combinations Ceased GB9901338D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9901338A GB9901338D0 (en) 1999-01-21 1999-01-21 Therapeutic combinations

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9901338A GB9901338D0 (en) 1999-01-21 1999-01-21 Therapeutic combinations
CA 2351057 CA2351057A1 (en) 1998-11-12 1999-11-10 Combination of a gaba-a alpha 5 inverse agonist and cox-2 inhibitor, nsaid, estrogen or vitamin e
PCT/US1999/026623 WO2000027382A3 (en) 1998-11-12 1999-11-10 Combination of a gaba-a alpha 5 inverse agonist and cox-2 inhibitor, nsaid, estrogen or vitamin e
EP19990960268 EP1131102A2 (en) 1998-11-12 1999-11-10 Combination of a gaba-a alpha 5 inverse agonist and cox-2 inhibitor, nsaid, estrogen or vitamin e
JP2000580611A JP2002529406A (en) 1998-11-12 1999-11-10 GABAAα5 opposite active agents, COX-2 inhibitors, the combination of the NSAID, estrogen or vitamin E

Publications (1)

Publication Number Publication Date
GB9901338D0 true GB9901338D0 (en) 1999-03-10

Family

ID=10846274

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9901338A Ceased GB9901338D0 (en) 1999-01-21 1999-01-21 Therapeutic combinations

Country Status (1)

Country Link
GB (1) GB9901338D0 (en)

Similar Documents

Publication Publication Date Title
GB9914486D0 (en) Medicaments
GB9930082D0 (en) Medicaments
GB9930085D0 (en) Medicaments
GB9915471D0 (en) Medicaments
GB9930106D0 (en) Medicaments
GB9930071D0 (en) Medicaments
GB9902251D0 (en) Medicaments
GB9910076D0 (en) Medicaments
GB9930075D0 (en) Medicaments
GB9930079D0 (en) Medicaments
GB9923675D0 (en) Medicaments
GB9929039D0 (en) Medicaments
GB9904935D0 (en) Medicaments
GB9924990D0 (en) Medicaments
GB9901236D0 (en) Medicaments
GB9927698D0 (en) Therapeutic antibody
GB9903584D0 (en) Modified calycins
GB9925815D0 (en) Divided sauce-pan
GB9923653D0 (en) Klubb fit
GB9915021D0 (en) Lyrocane B
GB9903174D0 (en) Lyrocane B
DE60016385D1 (en) Maximum/minimum-thermometer
GB9912935D0 (en) Medical designs
GB9910529D0 (en) Medical designs
GB9914798D0 (en) Ensure

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)